YAZ, Yasmin and Ocella birth control pills
History of YAZ, Yasmin and Ocella
YAZ or Yasmin is an oral contraceptive drug, a birth control pill, sold by Bayer Healthcare Pharmaceuticals, Inc., one of the biggest drug companies in the world. After extensive testing, in 2001 a company named Berlex Laboratories, that was later acquired by Bayer, applied for and received approval from the United States Food and Drug Administration (FDA) to market and sell Yasmin in the United States.
Later, Bayer introduced a similar drug called YAZ, and in 2008 the drug Ocella with similar ingredients was introduced into the U.S. market by Barr Laboratories.
FDA says ads misleading
In October of 2008, after these three drugs had become the most popular birth control drugs in the U.S., the FDA informed Bayer that its advertising regarding YAZ was misleading in that it exaggerated the claims regarding the effectiveness of this drug. The FDA told Bayer that it had minimized the risks of serious side effects of using YAZ.
These side effects include the following:
- Blood clots
- Heart attacks
- Pulmonary embolisms
- Deep-vein thrombosis
- Cerebral hemorrhages
- Gallbladder complications
- Liver complications
FDA says ads overstate YAZ efficacy
The warning letter sent to Bayer in 2008 was for publishing two false and misleading television ads about Yaz. The FDA said that the ads overstated Yaz's efficacy, promoted it for conditions -- like premenstrual syndrome -- for which it is not approved, and downplayed serious risks associated with the drug. As a result, Bayer agreed in February 2009 to spend $20 million on an ad campaign to correct the misimpressions from the earlier campaign.
Reliance on ads
Because of the reliance on these misleading ads, our law firm is currently investigating cases against Bayer in which our clients have sustained any of the injuries shown above to be side effects of YAZ, Yasmin or Ocella.
If you or a loved one has taken any of these drugs and suffered any of the side effects shown above, call us today for an immediate, free consultation at 1-800-882-1402, or email us at firstname.lastname@example.org. You can also submit any questions you may want us to answer by going to the “Contact Us” page in this website.